Conditions: Schizophrenia
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 457
Healthy volunteers: no

Brief summary:
The study evaluates the efficacy and safety of SM-13496 compared with placebo in patients with schizophrenia.

Detailed description:

Arms:
arm 1: None arm 2: None arm 3: None

Interventions: intervention 1: SM-13496 40mg intervention 2: SM-13496 80mg intervention 3: Placebo
Intervention descriptions: intervention 1: once daily orally intervention 2: once daily orally intervention 3: once daily orally

Protocol document: